January 17, 2012 – Recently, the European Medicines Agency (EMA) has announced that it  is reviewing aliskiren-containing medicines, to assess the impact of data coming from the ALTITUDE study on the balance of benefits and risks of these medicines in their approved indication. Aliskiren-containing …

European Medicines Agency (EMA) starts review of aliskiren-containing medicines Read more »